机构:[1]Department of Pharmacy, Xuanwu Hospital of Capital Medical University, 45 Changchun Road, Xicheng District, Beijing 100053, China药物学研究室[2]Renaissance School of Medicine at Stony Brook University, NY 11794, USA[3]Department of Pharmacy, Chinese PLA General Hospital, Beijing 100853, China[4]Department of Clinical Pharmacology, General Hospital of Chinese PLA, 28 Fuxing Road, Haidian District, Beijing 100853, China
第一作者机构:[1]Department of Pharmacy, Xuanwu Hospital of Capital Medical University, 45 Changchun Road, Xicheng District, Beijing 100053, China
通讯作者:
通讯机构:[1]Department of Pharmacy, Xuanwu Hospital of Capital Medical University, 45 Changchun Road, Xicheng District, Beijing 100053, China[3]Department of Pharmacy, Chinese PLA General Hospital, Beijing 100853, China[4]Department of Clinical Pharmacology, General Hospital of Chinese PLA, 28 Fuxing Road, Haidian District, Beijing 100853, China
推荐引用方式(GB/T 7714):
Xian‑Zhe Dong,Zi‑Run Zhao,Yuan Hu,et al.LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis[J].GASTRIC CANCER.2020,23(2):260-272.doi:10.1007/s10120-019-01011-0.
APA:
Xian‑Zhe Dong,Zi‑Run Zhao,Yuan Hu,Yu‑Pan Lu,Ping Liu&Lan Zhang.(2020).LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis.GASTRIC CANCER,23,(2)
MLA:
Xian‑Zhe Dong,et al."LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis".GASTRIC CANCER 23..2(2020):260-272